# Loxapine

NDC: 0591-0372
Generic name: Loxapine
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 19880615

FDA application: ANDA072062

## Active ingredients

- LOXAPINE SUCCINATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0591-0372"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0591-0372
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6107bb1-3e23-4c5d-bbf4-5e29deff6728